UBS raised the firm’s price target on Intuitive Surgical (ISRG) to $600 from $585 and keeps a Neutral rating on the shares. Strong procedure volume growth and system placements are likely to help sustain the stock’s momentum, the analyst tells investors in a post-earnings note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG: